IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $243,680 | -39.1% | 53,556 | -5.7% | 0.00% | 0.0% |
| Q2 2023 | $399,872 | +46.5% | 56,800 | +129.9% | 0.00% | 0.0% |
| Q2 2022 | $273,000 | -62.7% | 24,704 | -35.5% | 0.00% | -50.0% |
| Q4 2021 | $731,000 | +45.3% | 38,284 | +88.0% | 0.00% | 0.0% |
| Q3 2021 | $503,000 | -75.3% | 20,369 | -73.9% | 0.00% | -75.0% |
| Q2 2021 | $2,033,000 | -2.2% | 78,127 | +19.0% | 0.01% | -11.1% |
| Q1 2021 | $2,078,000 | -0.7% | 65,638 | -6.1% | 0.01% | -43.8% |
| Q1 2020 | $2,093,000 | – | 69,924 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MHR Fund Management | 11,997,103 | $84,459,605 | 11.88% |
| MPM BioImpact LLC | 2,950,118 | $20,768,831 | 4.18% |
| Perceptive Advisors | 14,036,410 | $98,816,326 | 2.86% |
| Velan Capital Investment Management LP | 240,000 | $1,689,600 | 1.57% |
| Parametrica Management Ltd | 96,500 | $679,360 | 1.31% |
| Boxer Capital, LLC | 3,705,133 | $26,084 | 1.21% |
| Soleus Capital Management, L.P. | 1,239,777 | $8,728,030 | 0.97% |
| Opaleye Management Inc. | 421,000 | $2,963,840 | 0.71% |
| 683 Capital Management, LLC | 1,400,000 | $9,856,000 | 0.71% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,758,759 | $12,381,665 | 0.70% |